Upgrades
According to Macquarie, the prior rating for 2U Inc (NASDAQ:TWOU) was changed from Neutral to Outperform. In the first quarter, 2U showed an EPS of $0.12, compared to $0.33 from the year-ago quarter. At the moment, the stock has a 52-week-high of $59.74 and a 52-week-low of $28.45. 2U closed at $44.20 at the end of the last trading period.
According to Guggenheim, the prior rating for Covetrus Inc (NASDAQ:CVET) was changed from Neutral to Buy. In the first quarter, Covetrus showed an EPS of $0.21, compared to $0.18 from the year-ago quarter. The stock has a 52-week-high of $40.77 and a 52-week-low of $18.14. At the end of the last trading period, Covetrus closed at $26.10.
For Heska Corp (NASDAQ:HSKA), Guggenheim upgraded the previous rating of Neutral to Buy. In the first quarter, Heska showed an EPS of $0.59, compared to $0.14 from the year-ago quarter. The stock has a 52-week-high of $238.69 and a 52-week-low of $86.82. At the end of the last trading period, Heska closed at $237.04.
According to Citigroup, the prior rating for Invesco Ltd (NYSE:IVZ) was changed from Neutral to Buy. For the first quarter, Invesco had an EPS of $0.68, compared to year-ago quarter EPS of $0.34. The stock has a 52-week-high of $29.71 and a 52-week-low of $9.72. At the end of the last trading period, Invesco closed at $26.33.
B of A Securities upgraded the previous rating for Greenbrier Companies Inc (NYSE:GBX) from Underperform to Buy. Greenbrier Companies earned $0.69 in the third quarter, compared to $1.05 in the year-ago quarter. The stock has a 52-week-high of $50.21 and a 52-week-low of $21.61. At the end of the last trading period, Greenbrier Companies closed at $43.27.
For Manulife Financial Corp (NYSE:MFC), Barclays upgraded the previous rating of Equal-Weight to Overweight. Manulife Financial earned $0.65 in the first quarter, compared to $0.38 in the year-ago quarter. At the moment, the stock has a 52-week-high of $22.25 and a 52-week-low of $13.11. Manulife Financial closed at $19.25 at the end of the last trading period.
JP Morgan upgraded the previous rating for JC Decaux SA (OTC:JCDXF) from Neutral to Overweight. The current stock performance of JC Decaux shows a 52-week-high of $30.03 and a 52-week-low of $15.30. Moreover, at the end of the last trading period, the closing price was at $27.70.
For Heineken NV (OTC:HEINY), JP Morgan upgraded the previous rating of Neutral to Overweight. The current stock performance of Heineken shows a 52-week-high of $61.88 and a 52-week-low of $43.12. Moreover, at the end of the last trading period, the closing price was at $59.05.
RBC Capital upgraded the previous rating for Hays PLC (OTC:HAYPF) from Sector Perform to Outperform. The current stock performance of Hays shows a 52-week-high of $1.59 and a 52-week-low of $1.59. Moreover, at the end of the last trading period, the closing price was at $1.59.
See all analyst ratings upgrades.
Downgrades
For Stamps.com Inc (NASDAQ:STMP), Craig-Hallum downgraded the previous rating of Buy to Hold. Stamps.com earned $2.08 in the first quarter, compared to $1.32 in the year-ago quarter. At the moment, the stock has a 52-week-high of $325.13 and a 52-week-low of $159.22. Stamps.com closed at $324.23 at the end of the last trading period.
According to Wolfe Research, the prior rating for Watsco Inc (NYSE:WSO) was changed from Peer Perform to Underperform. Watsco earned $1.39 in the first quarter, compared to $0.72 in the year-ago quarter. At the moment, the stock has a 52-week-high of $307.81 and a 52-week-low of $182.35. Watsco closed at $291.17 at the end of the last trading period.
Wolfe Research downgraded the previous rating for 3M Co (NYSE:MMM) from Peer Perform to Underperform. 3M earned $2.77 in the first quarter, compared to $2.16 in the year-ago quarter. At the moment, the stock has a 52-week-high of $208.95 and a 52-week-low of $148.80. 3M closed at $201.00 at the end of the last trading period.
According to Maxim Group, the prior rating for Stamps.com Inc (NASDAQ:STMP) was changed from Buy to Hold. For the first quarter, Stamps.com had an EPS of $2.08, compared to year-ago quarter EPS of $1.32. The stock has a 52-week-high of $325.13 and a 52-week-low of $159.22. At the end of the last trading period, Stamps.com closed at $324.23.
According to JP Morgan, the prior rating for Clover Health Investments Corp (NASDAQ:CLOV) was changed from Neutral to Underweight. Clover Health Investments earned $0.12 in the first quarter. The stock has a 52-week-high of $28.85 and a 52-week-low of $6.31. At the end of the last trading period, Clover Health Investments closed at $9.27.
RBC Capital downgraded the previous rating for Randstad NV (OTC:RANJY) from Outperform to Sector Perform. The current stock performance of Randstad shows a 52-week-high of $40.44 and a 52-week-low of $23.04. Moreover, at the end of the last trading period, the closing price was at $38.93.
For Rocket Companies Inc (NYSE:RKT), Jefferies downgraded the previous rating of Buy to Hold. Interestingly, in the first quarter, Rocket Companies's EPS was $0.89. At the moment, the stock has a 52-week-high of $43.00 and a 52-week-low of $16.22. Rocket Companies closed at $19.03 at the end of the last trading period.
See all analyst ratings downgrades.
Initiations
B. Riley Securities initiated coverage on Angel Oak Mortgage Inc (NYSE:AOMR) with a Buy rating. The price target for Angel Oak Mortgage is set to $22.00. The stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . At the end of the last trading period, Angel Oak Mortgage closed at $17.09.
Canaccord Genuity initiated coverage on Convey Holding Parent Inc (NYSE:CNVY) with a Buy rating. The price target for Convey Holding Parent is set to $18.00. At the moment, the stock has a 52-week-high of $14.29 and a 52-week-low of $9.11. Convey Holding Parent closed at $9.88 at the end of the last trading period.
Craig-Hallum initiated coverage on Indie Semiconductor Inc (NASDAQ:INDI) with a Buy rating. The price target for Indie Semiconductor is set to $18.00. The stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . At the end of the last trading period, Indie Semiconductor closed at $9.06.
Truist Securities initiated coverage on Convey Holding Parent Inc (NYSE:CNVY) with a Buy rating. The price target for Convey Holding Parent is set to $16.00. The stock has a 52-week-high of $14.29 and a 52-week-low of $9.11. At the end of the last trading period, Convey Holding Parent closed at $9.88.
Morgan Stanley initiated coverage on Lyell Immunopharma Inc (NASDAQ:LYEL) with an Overweight rating. The price target for Lyell Immunopharma is set to $25.00. At the moment, the stock has a 52-week-high of $18.90 and a 52-week-low of $14.98. Lyell Immunopharma closed at $15.88 at the end of the last trading period.
With a Equal-Weight rating, Morgan Stanley initiated coverage on UWM Holdings Corp (NYSE:UWMC). The price target seems to have been set at $8.00 for UWM Holdings. In the first quarter, UWM Holdings earned $0.33. At the moment, the stock has a 52-week-high of $12.45 and a 52-week-low of $6.25. UWM Holdings closed at $8.17 at the end of the last trading period.
With an Outperform rating, William Blair initiated coverage on Verve Therapeutics Inc (NASDAQ:VERV). The price target seems to have been set at $92.00 for Verve Therapeutics. At the moment, the stock has a 52-week-high of $73.80 and a 52-week-low of $29.50. Verve Therapeutics closed at $46.00 at the end of the last trading period.
With a Buy rating, Guggenheim initiated coverage on Verve Therapeutics Inc (NASDAQ:VERV). The price target seems to have been set at $84.00 for Verve Therapeutics. At the moment, the stock has a 52-week-high of $73.80 and a 52-week-low of $29.50. Verve Therapeutics closed at $46.00 at the end of the last trading period.
With an Overweight rating, Morgan Stanley initiated coverage on WalkMe Ltd (NASDAQ:WKME). The price target seems to have been set at $41.00 for WalkMe. At the moment, the stock has a 52-week-high of $31.64 and a 52-week-low of $27.25. WalkMe closed at $30.89 at the end of the last trading period.
With an Overweight rating, Wells Fargo initiated coverage on WalkMe Ltd (NASDAQ:WKME). The price target seems to have been set at $40.00 for WalkMe. At the moment, the stock has a 52-week-high of $31.64 and a 52-week-low of $27.25. WalkMe closed at $30.89 at the end of the last trading period.
With a Market Outperform rating, JMP Securities initiated coverage on WalkMe Ltd (NASDAQ:WKME). The price target seems to have been set at $39.00 for WalkMe. At the moment, the stock has a 52-week-high of $31.64 and a 52-week-low of $27.25. WalkMe closed at $30.89 at the end of the last trading period.
Citigroup initiated coverage on WalkMe Ltd (NASDAQ:WKME) with a Buy rating. The price target for WalkMe is set to $40.00. The stock has a 52-week-high of $31.64 and a 52-week-low of $27.25. At the end of the last trading period, WalkMe closed at $30.89.
UBS initiated coverage on Angel Oak Mortgage Inc (NYSE:AOMR) with a Buy rating. The price target for Angel Oak Mortgage is set to $19.50. The stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . At the end of the last trading period, Angel Oak Mortgage closed at $17.09.
With an Overweight rating, Barclays initiated coverage on WalkMe Ltd (NASDAQ:WKME). The price target seems to have been set at $36.00 for WalkMe. The stock has a 52-week-high of $31.64 and a 52-week-low of $27.25. At the end of the last trading period, WalkMe closed at $30.89.
Barclays initiated coverage on AST SpaceMobile Inc (NASDAQ:ASTS) with an Overweight rating. The price target for AST SpaceMobile is set to $29.00. In the first quarter, AST SpaceMobile earned $0.00. The stock has a 52-week-high of $15.48 and a 52-week-low of $6.96. At the end of the last trading period, AST SpaceMobile closed at $12.76.
Needham initiated coverage on WalkMe Ltd (NASDAQ:WKME) with a Buy rating. The price target for WalkMe is set to $40.00. The current stock performance of WalkMe shows a 52-week-high of $31.64 and a 52-week-low of $27.25. Moreover, at the end of the last trading period, the closing price was at $30.89.
Piper Sandler initiated coverage on LiveVox Holdings Inc (NASDAQ:LVOX) with an Overweight rating. The price target for LiveVox Hldgs is set to $12.00. At the moment, the stock has a 52-week-high of $9.45 and a 52-week-low of $8.00. LiveVox Hldgs closed at $8.55 at the end of the last trading period.
With a Neutral rating, JP Morgan initiated coverage on Verve Therapeutics Inc (NASDAQ:VERV). The price target seems to have been set at $50.00 for Verve Therapeutics. At the moment, the stock has a 52-week-high of $73.80 and a 52-week-low of $29.50. Verve Therapeutics closed at $46.00 at the end of the last trading period.
JP Morgan initiated coverage on Convey Holding Parent Inc (NYSE:CNVY) with a Neutral rating. The price target for Convey Holding Parent is set to $12.00. The stock has a 52-week-high of $14.29 and a 52-week-low of $9.11. At the end of the last trading period, Convey Holding Parent closed at $9.88.
With an Overweight rating, JP Morgan initiated coverage on Lyell Immunopharma Inc (NASDAQ:LYEL). The price target seems to have been set at $22.00 for Lyell Immunopharma. The stock has a 52-week-high of $18.90 and a 52-week-low of $14.98. At the end of the last trading period, Lyell Immunopharma closed at $15.88.
Jefferies initiated coverage on Verve Therapeutics Inc (NASDAQ:VERV) with a Buy rating. The stock has a 52-week-high of $73.80 and a 52-week-low of $29.50. At the end of the last trading period, Verve Therapeutics closed at $46.00.
Berenberg initiated coverage on Medigene AG (OTC:MDGEF) with a Buy rating. The stock has a 52-week-high of $6.68 and a 52-week-low of $3.92. At the end of the last trading period, Medigene closed at $4.90.
Goldman Sachs initiated coverage on WalkMe Ltd (NASDAQ:WKME) with a Buy rating. The price target for WalkMe is set to $47.00. At the moment, the stock has a 52-week-high of $31.64 and a 52-week-low of $27.25. WalkMe closed at $30.89 at the end of the last trading period.
Goldman Sachs initiated coverage on Lyell Immunopharma Inc (NASDAQ:LYEL) with a Buy rating. The price target for Lyell Immunopharma is set to $30.00. At the moment, the stock has a 52-week-high of $18.90 and a 52-week-low of $14.98. Lyell Immunopharma closed at $15.88 at the end of the last trading period.
With an Outperform rating, BMO Capital initiated coverage on WalkMe Ltd (NASDAQ:WKME). The price target seems to have been set at $35.00 for WalkMe. The current stock performance of WalkMe shows a 52-week-high of $31.64 and a 52-week-low of $27.25. Moreover, at the end of the last trading period, the closing price was at $30.89.
With an Overweight rating, Keybanc initiated coverage on WalkMe Ltd (NASDAQ:WKME). The price target seems to have been set at $42.00 for WalkMe. At the moment, the stock has a 52-week-high of $31.64 and a 52-week-low of $27.25. WalkMe closed at $30.89 at the end of the last trading period.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
